Seres Therapeutics Inc - MCRB - stock price prediction, stock price target, analyst ratings from 2 analysts

Seres Therapeutics Inc has a share price target of US$ 17, revenue growth forecast of 1646.8%, and profit growth estimate of -757.7% for FY26, based on top 2 analyst calls.